688298.SH
东方生物
SSE · Healthcare · Medical - Specialties · CN
CNY 18.71
−3.71%Margins
Gross margin
43.9%
EBITDA margin
-37.5%
EBIT margin
-54.5%
Net margin
-54.6%
FCF margin
-45.1%
-9.4%
Return on equity
-8.0%
Return on assets
-9.0%
Return on invested capital
0.14x
Asset turnover
-CNY 168.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026